OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.900
-0.090 (-3.01%)
Nov 4, 2024, 4:00 PM EST - Market closed
OncoCyte Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for OncoCyte stock have an average target of 4.06, with a low estimate of 3.00 and a high estimate of 5.00. The average target predicts an increase of 40.00% from the current stock price of 2.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for OncoCyte stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +46.55% | Oct 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +46.55% | Aug 9, 2024 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | +46.55% | May 16, 2024 |
| Needham | Needham | Strong Buy Maintains $3.6 → $4.25 | Strong Buy | Maintains | $3.6 → $4.25 | +46.55% | Apr 24, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $4 | Hold | Reiterates | $4 | +37.93% | Apr 17, 2024 |
Financial Forecast
Revenue This Year
669.96K
from 1.50M
Decreased by -55.42%
Revenue Next Year
1.80M
from 669.96K
Increased by 167.93%
EPS This Year
-2.31
from -3.75
EPS Next Year
-1.85
from -2.31
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.1M | 2.3M | 9.7M |
| Avg | 669,963 | 1.8M | 7.2M |
| Low | 480,200 | 1.0M | 4.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -30.1% | 244.8% | 438.2% |
| Avg | -55.4% | 167.9% | 299.5% |
| Low | -68.1% | 50.8% | 173.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.25 | -1.92 | -1.62 |
| Avg | -2.31 | -1.85 | -1.56 |
| Low | -2.38 | -1.79 | -1.51 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.